Risedronate therapy for the prevention of steroid-induced osteoporosis in patients with minimal-change nephrotic syndrome.
Takei T, Itabashi M, Tsukada M, Sugiura H, Moriyama T, Kojima C, Shiohira S, Shimizu A, Karasawa K, Amemiya N, Kawanishi K, Ogawa T, Uchida K, Tsuchiya K, Nitta K.
Takei T, et al. Among authors: karasawa k.
Intern Med. 2010;49(19):2065-70. doi: 10.2169/internalmedicine.49.3707. Epub 2010 Oct 1.
Intern Med. 2010.
PMID: 20930431
Free article.
Clinical Trial.